Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value:
$115.88M
Total Bought:
$29.35M
Total Sold:
$11.86M
Net Transaction:
+$17.49M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Jasper Therapeutics, Inc.(JSPR)1,433,8281,433,8280$26.97M$30.66M26.45%+$3.68M
Praxis Precision Medicines, Inc.(PRAX)350,666300,000-50,666$20.18M$23.09M19.92%+$2.91M
Heron Therapeutics, Inc.(HRTX)6,986,7446,986,7440$13.90M$10.69M9.22%-$3.21M
Tourmaline Bio Inc331,190423,795+92,605$8.51M$8.59M7.42%+$79.7K
Protara Therapeutics, Inc.(TARA)574,0001,579,000+1,005,000$1.05M$8.34M7.19%+$7.29M
Springworks Therapeutics Inc0185,520+185,520$0$6.70M5.78%+$6.70M
Rezolute, Inc.(RZLT)800,000800,0000$3.88M$3.92M3.38%+$40.0K
Liquidia Corporation(LQDA)300,000300,0000$3.00M$3.53M3.04%+$528.0K
Zevra Therapeutics, Inc.(ZVRA)200,000300,000+100,000$1.39M$2.50M2.16%+$1.11M
InspireMD, Inc.(NSPR)904,029904,0290$2.42M$2.38M2.05%-$45.2K
Verona Pharma PlcADS050,000+50,000$0$2.32M2.00%+$2.32M
Replimune Group, Inc.(REPL)0181,367+181,367$0$2.20M1.90%+$2.20M
Nurix Therapeutics, Inc.(NRIX)097,889+97,889$0$1.84M1.59%+$1.84M
Perspective Therapeutics, Inc.(CATX)0500,000+500,000$0$1.59M1.38%+$1.59M
Eledon Pharmaceuticals, Inc.(ELDN)0323,973+323,973$0$1.33M1.15%+$1.33M
Kura Oncology, Inc.(KURA)0150,000+150,000$0$1.31M1.13%+$1.31M
Collegium Pharmaceutical, Inc.(COLL)028,685+28,685$0$821.8K0.71%+$821.8K
Avalo Therapeutics, Inc.(AVTX)0109,972+109,972$0$817.1K0.71%+$817.1K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)50,00056,700+6,700$1.03M$669.1K0.58%-$362.4K
Tenax Therapeutics, Inc.(TENX)83,33383,3330$288.3K$515.8K0.45%+$227.5K
Kiora Pharmaceuticals, Inc.(KPRX)122,223122,2230$447.3K$403.3K0.35%-$44.0K
Geron Corporation(GERN)049,000+49,000$0$173.5K0.15%+$173.5K
Wave Life Sciences, Inc.SHS(WVE)013,000+13,000$0$160.8K0.14%+$160.8K
Regulus Therapeutics Inc070,000+70,000$0$110.6K0.10%+$110.6K
Proqr Thrapeutics N VSHS EURO
SHS EURO
040,500+40,500$0$107.3K0.09%+$107.3K
Alector Inc055,000+55,000$0$104.0K0.09%+$104.0K
Context Therapeutics Inc.(CNTX)1,290,32390,000-1,200,323$2.53M$94.5K0.08%-$2.43M
Terns Pharmaceuticals Inc017,000+17,000$0$94.2K0.08%+$94.2K
Ventyx Biosciences Inc035,000+35,000$0$76.7K0.07%+$76.7K
Enanta Pharmaceuticals, Inc.(ENTA)013,000+13,000$0$74.8K0.06%+$74.8K
Larimar Therapeutics, Inc.(LRMR)018,000+18,000$0$69.7K0.06%+$69.7K
Gossamer Bio, Inc.(GOSS)075,000+75,000$0$67.8K0.06%+$67.8K
Aclaris Therapeutics, Inc.(ACRS)027,000+27,000$0$67.0K0.06%+$67.0K
Ovid Therapeutics Inc.(OVID)070,000+70,000$0$65.4K0.06%+$65.4K
4d Molecular Therapeutics In010,000+10,000$0$55.7K0.05%+$55.7K
Sutro Biopharma, Inc.(STRO)030,000+30,000$0$55.2K0.05%+$55.2K
PMV Pharmaceuticals, Inc.(PMVP)035,000+35,000$0$52.9K0.05%+$52.9K
Fibrogen Inc080,000+80,000$0$42.4K0.04%+$42.4K
CytomX Therapeutics, Inc.(CTMX)035,000+35,000$0$36.0K0.03%+$36.0K
Kronos Bio Inc035,000+35,000$0$33.3K0.03%+$33.3K
Karyopharm Therapeutics Inc.(KPTI)040,000+40,000$0$27.1K0.02%+$27.1K
Bolt Biotherapeutics Inc050,000+50,000$0$26.8K0.02%+$26.8K
Elevation Oncology Inc045,000+45,000$0$25.3K0.02%+$25.3K
Cocrystal Pharma, Inc.(COCP)010,000+10,000$0$20.2K0.02%+$20.2K
Nextcure Inc025,000+25,000$0$19.3K0.02%+$19.3K
Optinose Inc2,146,6080-2,146,608$1.44M$0—-$1.44M
Scpharmaceuticals Inc517,6680-517,668$2.36M$0—-$2.36M
Skye Bioscience, Inc.(SKYE)211,0710-211,071$825.3K$0—-$825.3K
TELA Bio, Inc.(TELA)747,4100-747,410$1.89M$0—-$1.89M
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q4 2024 | TickerTrail